BRIEF published on 01/17/2025 at 22:33, 1 year 3 months ago Moderna Advances mRNA-Based Influenza Vaccine Development Clinical Trials Moderna MRNA Vaccines BARDA Funding Influenza
PRESS RELEASE published on 01/17/2025 at 22:28, 1 year 3 months ago Moderna Announces Updates on Pandemic Influenza Program Moderna announces ongoing support from HHS to accelerate mRNA-based pandemic influenza vaccines development. Award received through BARDA-funded RRPV Consortium Moderna MRNA BARDA HHS Pandemic Influenza Vaccines
BRIEF published on 01/13/2025 at 13:05, 1 year 3 months ago Moderna Outlines Strategic Moves at J.P. Morgan Healthcare Conference Cost Reduction Plan Vaccine Approvals Moderna Financials 2025 Revenue Forecast Pipeline Milestones
BRIEF published on 01/13/2025 at 13:05, 1 year 3 months ago Moderna présente ses orientations stratégiques lors de la conférence JP Morgan Healthcare Approbations De Vaccins Finances Moderna Prévisions De Revenus Pour 2025 Plan De Réduction Des Coûts Étapes Clés Du Pipeline
PRESS RELEASE published on 01/13/2025 at 13:00, 1 year 3 months ago Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference Moderna, Inc. announces 2024 financial achievements and 2025 projections with emphasis on revenue growth, cost reductions, and pipeline milestones including COVID-19 and flu vaccines Revenue Growth Financial Updates Moderna Cost Reductions Pipeline Milestones
BRIEF published on 11/25/2024 at 13:05, 1 year 5 months ago Moderna to Present at December 2024 Investor Conferences Investor Conferences Healthcare Webcast MRNA Technology Moderna
BRIEF published on 11/25/2024 at 13:05, 1 year 5 months ago Moderna présentera ses résultats financiers lors des conférences d'investisseurs de décembre 2024 Webcast Soins De Santé Conférences D'investisseurs Moderne Technologie De L'ARNm
PRESS RELEASE published on 11/25/2024 at 13:00, 1 year 5 months ago Moderna to Present at Upcoming Conferences in December 2024 Moderna, Inc. announces participation in investor conferences and highlights mRNA technology advancements. Company overview and contact info provided Investor Conferences Healthcare MRNA Technology Moderna Vaccines
BRIEF published on 11/12/2024 at 14:20, 1 year 6 months ago Moderna Tops BioSpace's Best Places to Work for Fourth Year Innovation AI Integration Life Sciences Moderna Workplace Ranking
BRIEF published on 11/12/2024 at 14:20, 1 year 6 months ago Moderna est en tête du classement des meilleurs lieux de travail de BioSpace pour la quatrième année consécutive Innovation Intégration De L'IA Moderne Sciences De La Vie Classement Des Lieux De Travail
Published on 05/13/2026 at 00:00, 6 hours 8 minutes ago Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
Published on 05/12/2026 at 23:35, 6 hours 33 minutes ago Infield Minerals Closes $1.25 Million Financing
Published on 05/12/2026 at 21:55, 8 hours 13 minutes ago UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/12/2026 at 21:42, 8 hours 26 minutes ago Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026
Published on 05/13/2026 at 04:00, 2 hours 7 minutes ago Siam Piwat redefines global retail with NEXTOPIA, a future prototype where sustainability is a transformative force for business, people, and the planet
Published on 05/12/2026 at 23:47, 6 hours 20 minutes ago Nebius welcomes Clarifai’s core team and licenses inference IP to strengthen Nebius Token Factory
Published on 05/12/2026 at 22:25, 7 hours 42 minutes ago Evotec SE Successfully Placed €116.1 Million Convertible Bonds
Published on 05/12/2026 at 20:21, 9 hours 46 minutes ago Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 10 hours 32 minutes ago AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 18:15, 11 hours 53 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 11 hours 53 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 11 hours 58 minutes ago imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
Published on 05/12/2026 at 18:10, 11 hours 58 minutes ago imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:50, 12 hours 18 minutes ago Damartex fait évoluer sa gouvernance et engage une réflexion stratégique autour de ses activités
